Table 1.
The general information and laboratory data of the new diagnosed type 2 diabetic patients and non-diabetes mellitus.
| Control | T2DM | |
|---|---|---|
| Participants (M/F) | 35 (18/17) | 38 (18/20) |
| Age (years) | 43 ± 13 | 45 ± 10 |
| Body mass index (kg/m2) | 23.9 ± 3.3 | 25.5 ± 4.9 |
| Waist circumference (cm) | 83.1 ± 6.0 | 92.2 ± 5.1 |
| Systolic pressure (mmHg) | 125.1 ± 12.4 | 138.0 ± 18.3 |
| Diastolic pressure (mmHg) | 78.3 ± 8.2 | 86.1 ± 9.3 |
| Fasting plasma glucose (mM) | 6.1 ± 0.9 | 7.4 ± 1.7* |
| HbA1c (%) | 6.0 ± 0.6 | 7.1 ± 0.6* |
| Fasting insulin (mIU/L) | 5.7 ± 2.8 | 9.2 ± 6.2* |
| HOMA-IR | 3.3 (2.5~4.6) | 5.5 (3.6~6.7)* |
| Fasting serum resistin (ng/mL) | 6.1 ± 0.6 | 12.3 ± 2.7* |
| Fasting saliva resistin (ng/mL) | 1.5 ± 0.3# | 3.4 ± 0.4∗# |
| Fasting saliva flow rate (mL/min) | 2.2 ± 0.8 | 2.4 ± 1.1 |
Results are displayed as mean values ± standard deviation. Data of nonnormal distribution were described using the median (M) and quartile (Q1~Q4).
*P < 0.05: comparison of resistin level between T2DM group and non-diabetes mellitus group.
# P < 0.01: comparison between serum resistin level and saliva resistin level.